COVID-19 Related Health and Infection Control Practices Among Dentists

Severe Acute Respiratory Syndrome Coronavirus 2 Clinical Trial

Official title:

COVID-19 Related Health and Infection Control Practices Among Dentists

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04423770
• Other study ID #: 20-08
• Status: Completed
• Start date: June 8, 2020
• Est. completion date: June 8, 2021

Study information

• Verified date: July 2021
• Source: American Dental Association
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

As dentists begin reopening their practices during a global pandemic, the risk of COVID-19 infection that dentists face in providing dental care remains unknown. Estimating the occupational risk of COVID-19, and producing evidence on the types of infection control practices and dental practices that may affect COVID-19 risk, is therefore imperative. The goal of the proposed study is to understand U.S.-based dentists' health and dental-practice reactions to COVID-19. To estimate this, U.S-based dentists will be surveyed monthly. These findings could be used to describe the prevalence and incidence of COVID-19 among dentists, determine what infection control steps dentists take over time, and estimate whether infection control adherence in dental practice is related to COVID-19 incidence.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 2196
• Est. completion date: June 8, 2021
• Est. primary completion date: June 8, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Primary dental practice is in United States

• 18 years of age or older

• Dentist

Exclusion Criteria:

•Answered "no" to ADA survey sent May 2020 that read "As part of ongoing efforts to monitor the effect of COVID-19 on the dental team, the ADA is interested in collecting data related to infection rates. Would you also be willing to participate in a separate, longitudinal study that would require you to report whether you or your staff have exhibited symptoms of COVID-19, and whether you have been tested or diagnosed? The study would be anonymous and under IRB protocols."

Related Conditions & MeSH terms

• Infection
• Severe Acute Respiratory Syndrome
• Severe Acute Respiratory Syndrome Coronavirus 2

Intervention

Other:
• No intervention
No intervention; this is a purely observational study

Locations

Country	Name	City	State
United States	American Dental Association	Chicago	Illinois

Sponsors (1)

Lead Sponsor	Collaborator
American Dental Association

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	COVID-19 probable or confirmed case	COVID-19 case as confirmed by clinician and/or detection of SARS-CoV-2 RNA or a specific antigen in a clinical specimen	18 months
Secondary	Anxiety	Assessed using the Patient Health Questionnaire for Depression and Anxiety (PHQ-4). Two items scored 0 to 3 (total score of 0-6), with higher numbers indicating greater anxiety.	12 months
Secondary	Depression	Assessed using the Patient Health Questionnaire for Depression and Anxiety (PHQ-4). Two items scored 0 to 3 (total score of 0-6), with higher numbers indicating greater depressive symptoms.	12 months
Secondary	Dental practice infection control efforts	Self-reports of infection control efforts in the respondents' primary dental practices	12 months
Secondary	Dentists' use of personal protective equipment	Self-reports of personal protective equipment use	12 months